NEWS
See the latest PIR International News, Articles and Network Updates.
Adrian Smith – BioLeader Interview
Chief Executive Officer, Oxford Gene Technology (August 2023) Adrian Smith is the CEO of Oxford Gene Technology, a Genomic testing company working in the areas of cancer and hereditary disease. Prior to joining Oxford Gene Technology, Adrian spent 8 [...]
Dan Williams – BioLeader Interview
Chief Executive Officer, SynaptixBio (July 2023) Dan Williams is an accomplished biopharmaceuticals leader with two decades of industrial experience from bench to operational and scientific executive roles. During his career Dan has served as Vice President of Research Operations [...]
PIR International Supports Appointment of Senior Vice President of Chemistry at Amphista Therapeutics
PIR International is pleased to announce the placement of Giles Brown as SVP of Chemistry at Amphista Therapeutics. Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, is applying its proprietary degrader platform to advance new approaches [...]
Sabine Dandiguian – BioLeader Interview
Managing Partner, Jeito Capital (July 2023) Sabine Dandiguian is Managing Partner at Jeito Capital and has over 30 years of experience in the pharmaceutical and medical devices industry. These years of experience have enabled her to acquire in-depth operational [...]